Home » Newsletters » BioWorld Science

BioWorld Science

June 1, 2006

View Archived Issues

PRECiSE trials detail safety and efficacy of certolizumab in Crohn's disease

Methylnaltrexone shows efficacy in patients with opioid-induced constipation

VX-950 plus peg-interferon and ribavirin leads to undetectable hepatitis C virus

Studies show improved airway function with arformoterol in COPD patients

Dabigatran safety assessed in long-term open-label follow-up study

Clinical data on TNFerade in esophageal and pancreatic cancer reported

INKP-102 demonstrates superiority to Visicol in colonoscopy patients

Astellas files for Japanese approval of once-daily tacrolimus

New study of single dose velafermin for prevention of oral mucositis

Reduction in viral load in 10-day HIV study of SP-01A

Tissue Therapies' VitroGro used for culture of human embryonic stem cells

U.K. clearance for phase IIa study of BrachySil for pancreatic cancer

Dainippon licenses Dops rights to Chelsea Therapeutics

SC-409: p38 inhibition with therapeutic potential for asthma, COPD and RA

Evidence that systemic application of XG-102 is neuroprotective postischemic stroke

Merck corrects statistical method description used in Vioxx APPROVe study

Crucell tests H9N2 virosomal vaccine for avian flu

ImmuFact IMP-321 completes phase I studies

Avantogen and Innovate Oncology complete merger of key oncology program

VaxGen ends early stage meningitis B vaccine collaboration

Lyrica licensed in U.K. for GAD

Rotarix launched in U.K.

Macugen, new wet AMD treatment in U.K.

Novel antiinfective agents disclosed in recent patent literature

Novel agents for cardiovascular disorders disclosed in recent patent literature

Sphingosine kinase activators for dermatological disorders claimed in NeoPharm patent

New class of antimicrobial hexapeptides developed at Helix BioMedix

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...